{
    "title": "FDA Approves First CRISPR Gene Therapy for Sickle Cell Disease",
    "summary": "Casgevy becomes the first FDA-approved treatment utilizing CRISPR/Cas9 gene-editing technology, marking a historic milestone in medicine.",
    "date": "2023-12-08",
    "category": "Breakthrough",
    "source": "FDA News",
    "url": "https://www.fda.gov",
    "content": "The US Food and Drug Administration has approved Casgevy (exagamglogene autotemcel), a cell-based gene therapy for the treatment of sickle cell disease in patients 12 years and older."
}